Proton MR Spectroscopy of Tumefactive Demyelinating Lesions

References

1. ↵
   Mastrostefano R, Occhipinti E, Bigotti G, et al. Multiple sclerosis plaque simulating cerebral tumor: case report and review of the literature. Neurosurgery 1987;21:244–246

   PubMedWeb of Science
2. ↵
   Hunter SB, Ballinger WE Jr, Rubin JJ. Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med 1987;111:464–468

   PubMedWeb of Science
3. Giang DW, Poduri KR, Eskin TA, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiology 1992;34:150–154

   CrossRefPubMedWeb of Science
4. ↵
   Silva HC, Callegaro D, Marchiori PE, et al. Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system. Arq Neuropsiquiatr 1999;57:921–926

   CrossRefPubMed
5. Kalyan-Raman UP, Garwacki DJ, Elwood PW. Demyelinating disease of corpus callosum presenting as glioma on magnetic resonance scan: a case documented with pathological findings. Neurosurgery 1987;21:247–250

   PubMedWeb of Science
6. ↵
   Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiology 1996;38:560–565

   CrossRefPubMedWeb of Science
7. Kurihara N, Takahashi S, Furuta A, et al. MR imaging of multiple sclerosis simulating brain tumor. Clin Imaging 1996;20:171–177

   CrossRefPubMedWeb of Science
8. ↵
   Zagzag D, Miller DC, Kleinman GM, et al. Demyelinating disease versus tumor in surgical neuropathology: Clues to a correct pathological diagnosis. Am J Surg Pathol 1993;17:537–545

   CrossRefPubMedWeb of Science
9. ↵
   Nahser HC, Vieregge P, Nau HE, et al. Coincidence of multiple sclerosis and glioma: clinical and radiological remarks on two cases. Surg Neurol 1986;26:45–51

   CrossRefPubMedWeb of Science
10. Khan OA, Bauserman SC, Rothman MI, et al. Concurrence of multiple sclerosis and brain tumor: clinical considerations. Neurology 1997;48:1330–1333

    Abstract/FREE Full Text
11. ↵
    Ernst T, Chang L, Walot I, et al. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology 1998;51:1486–1488

    Abstract/FREE Full Text
12. ↵
    Usenius JP, Kauppinen RA, Vainio PA, et al. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 1994;18:705–713

    PubMed
13. Poptani H, Gupta RK, Roy R, et al. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593–1603

    Abstract
14. ↵
    Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:737–747

    Abstract
15. ↵
    Barker PB, Glickson JD, Bryan RN. In vivo magnetic resonance spectroscopy of human brain tumors. Top Magn Reson Imaging 1993;5:32–45

    PubMed
16. ↵
    Grossman RI, Lenkinski RE, Ramer KN, et al. MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992;13:1535–1543

    Abstract/FREE Full Text
17. ↵
    Arnold DL, Matthews PM, Francis GS, et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31:235–441

    CrossRefPubMedWeb of Science
18. ↵
    Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49–58

    Abstract/FREE Full Text
19. ↵
    Silver NC, Barker RA, MacManus DG, et al. Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. J Neurol 1997;244:204–207

    CrossRefPubMedWeb of Science
20. ↵
    Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–1627

    Abstract/FREE Full Text
21. ↵
    De Stefano N, Caramanos Z, Preul MC, et al. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 1998;44:273–278

    CrossRefPubMedWeb of Science
22. ↵
    Lin AP, Ross BD. Short-echo time proton MR spectroscopy in the presence of gadolinium. J Comput Assist Tomogr 2001;25:705–712

    CrossRefPubMed
23. ↵
    Smith JK, Kwock L, Castillo M. Effects of contrast material on single-volume proton MR spectroscopy. AJNR Am J Neuroradiol 2000;21:1084–1089

    Abstract/FREE Full Text
24. ↵
    Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001;22:1109–1116

    Abstract/FREE Full Text
25. ↵
    Nesbit GM, Forbes GS, Scheithauer BW, et al. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467–474

    PubMedWeb of Science
26. ↵
    Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993;33:18–27

    CrossRefPubMedWeb of Science
27. ↵
    Urenjak J, Williams SR, Gadian DG, et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–989

    Abstract
28. ↵
    Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–285

    CrossRefPubMedWeb of Science
29. ↵
    Brenner RE, Munro PM, Williams SC, et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737–745

    PubMedWeb of Science
30. ↵
    Bruhn H, Frahm J, Merboldt KD, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992;32:140–150

    CrossRefPubMedWeb of Science
31. ↵
    Simone IL, Tortorella C, Federico F, et al. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. J Neurol Sci 2001;182:143–150

    CrossRefPubMed
32. ↵
    Lopez-Villegas D, Lenkinski RE, Wehrli SL, et al. Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magn Reson Med 1995;34:32–38

    PubMed
33. ↵
    Tovi M, Hartman M, Lilja A, et al. MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens. Acta Radiol 1994;35:495–505

    PubMed
34. ↵
    Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology 1990;174:411–415

    CrossRefPubMedWeb of Science
35. ↵
    Vanneste JA, Bellot SM, Stam FC. Progressive multifocal leukoencephalopathy presenting as a single mass lesion. Eur Neurol 1984;23:113–118

    CrossRefPubMed
36. ↵
    Burtscher IM, Skagerberg G, Geijer B, et al. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 2000;21:84–93

    Abstract/FREE Full Text
37. ↵
    Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715–721

    PubMedWeb of Science